ID22957A - Senyawa dan penggunaannya - Google Patents
Senyawa dan penggunaannyaInfo
- Publication number
- ID22957A ID22957A IDP990201D ID990201D ID22957A ID 22957 A ID22957 A ID 22957A ID P990201 D IDP990201 D ID P990201D ID 990201 D ID990201 D ID 990201D ID 22957 A ID22957 A ID 22957A
- Authority
- ID
- Indonesia
- Prior art keywords
- compound
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9812413.4A GB9812413D0 (en) | 1998-06-10 | 1998-06-10 | Compound and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
ID22957A true ID22957A (id) | 1999-12-23 |
Family
ID=10833464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP990201D ID22957A (id) | 1998-06-10 | 1999-03-10 | Senyawa dan penggunaannya |
Country Status (31)
Country | Link |
---|---|
US (1) | US6333198B1 (de) |
EP (2) | EP1170588A1 (de) |
JP (1) | JP2989189B1 (de) |
KR (1) | KR100322354B1 (de) |
CN (2) | CN1238454A (de) |
AP (3) | AP9901481A0 (de) |
AR (1) | AR014074A1 (de) |
AT (1) | ATE218552T1 (de) |
AU (1) | AU2031999A (de) |
BR (1) | BR9900984A (de) |
CA (1) | CA2265194C (de) |
DE (1) | DE69901656T2 (de) |
DK (1) | DK0963980T3 (de) |
EA (1) | EA000666B1 (de) |
ES (1) | ES2178342T3 (de) |
GB (1) | GB9812413D0 (de) |
HR (1) | HRP990074A2 (de) |
HU (1) | HUP9900592A3 (de) |
ID (1) | ID22957A (de) |
MA (1) | MA24777A1 (de) |
NO (2) | NO991151L (de) |
NZ (1) | NZ334590A (de) |
PE (1) | PE20000332A1 (de) |
PL (1) | PL331870A1 (de) |
PT (1) | PT963980E (de) |
SG (1) | SG85628A1 (de) |
SI (1) | SI0963980T1 (de) |
TR (1) | TR199900520A2 (de) |
UY (1) | UY25946A1 (de) |
YU (1) | YU12399A (de) |
ZA (1) | ZA991951B (de) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020055177A1 (en) * | 1999-03-10 | 2002-05-09 | Glaxo Wellcome Inc. | Compound and its use |
GB2372988B (en) * | 2000-01-03 | 2004-04-07 | Rpg Life Sciences Ltd | A process for the preparation of 6-(2,3-Dichlorophenyl)-1,2,4- Triazine-3,5-Diamine, commonly known as Lamotrigine |
CA2433181C (en) | 2000-12-29 | 2005-11-22 | Pfizer Limited | Amlodipine hemifumarate |
US6653481B2 (en) | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
CA2433284A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Reference standards and processes for determining the purity or stability of amlodipine maleate |
EP1309558A1 (de) | 2000-12-29 | 2003-05-14 | Synthon Licensing, Ltd. | Aspartat-derivat von amlodipine als kalzium-kanal antagonist |
WO2002053541A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Amide derivative of amlodipine |
AP2003002820A0 (en) | 2000-12-29 | 2003-06-30 | Pfizer Ltd | "Process for making amlodipine maleate" |
MXPA03005882A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
EP1309557B9 (de) | 2000-12-29 | 2006-11-15 | Pfizer Limited | Amlodipin-hemimaleat |
DE10134980C2 (de) * | 2001-07-17 | 2003-05-28 | Helm Ag | Verfahren zur Herstellung von Lamotrigin |
CA2366521C (en) | 2001-12-24 | 2007-03-06 | Brantford Chemicals Inc. | A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines |
WO2003080065A1 (en) * | 2002-03-20 | 2003-10-02 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of quetiapine hemifumarate |
HU225667B1 (en) | 2002-09-20 | 2007-05-29 | Richter Gedeon Nyrt | Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine |
ES2209639B1 (es) | 2002-10-31 | 2005-08-01 | Vita Cientifica, S.L. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio. |
GB2395483A (en) * | 2003-07-03 | 2004-05-26 | Jubilant Organosys Ltd | Crystalline lamotrigine and its monohydrate |
CA2537271A1 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries, Ltd. | Process for preparation of rosuvastatin calcium |
CA2546701C (en) * | 2003-11-24 | 2010-07-27 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
WO2005056534A1 (en) * | 2003-12-02 | 2005-06-23 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
CA2554572A1 (en) * | 2004-01-30 | 2005-08-18 | Teva Pharmaceutical Industries Ltd. | Montelukast free acid polymorphs |
WO2005075427A2 (en) * | 2004-01-30 | 2005-08-18 | Teva Pharmaceutical Industries Ltd. | Montelukast sodium polymorphs |
MD2823G2 (ro) * | 2004-02-12 | 2006-05-31 | Институт Химии Академии Наук Молдовы | Procedeu de determinare cantitativă a sclareolului în extractele, obţinute din salvia de muscat |
DE602005015174D1 (de) * | 2004-04-21 | 2009-08-13 | Teva Pharma | Verfahren zur herstellung von montelukast-natrium |
TW200613294A (en) * | 2004-04-26 | 2006-05-01 | Teva Gyogyszergyar Reszvenytarsasag | Process for preparation of mycophenolic acid and ester derivatives thereof |
US20050250773A1 (en) * | 2004-04-27 | 2005-11-10 | Sandor Molnar | Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid |
US7439399B2 (en) * | 2004-06-28 | 2008-10-21 | Teva Pharmaceutical Fine Chemicals | Processes for the preparation of atomoxetine hydrochloride |
WO2006004976A2 (en) * | 2004-06-28 | 2006-01-12 | Teva Pharmaceutical Fine Chemicals S.R.L. | Process for the preparation of atomoxetine hydrochloride |
JP2007508379A (ja) * | 2004-07-13 | 2007-04-05 | テバ ファーマシューティカル インダストリーズ リミティド | Tempo媒介型酸化段階を包含するロスバスタチンの調製方法 |
WO2006012385A2 (en) * | 2004-07-20 | 2006-02-02 | Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg | Crystalline mycophenolate sodium |
WO2006020348A2 (en) * | 2004-07-22 | 2006-02-23 | Teva Pharmaceutical Fine Chemicals S.R.L. | Polymorphs of atomoxetine hydrochloride |
US7629461B2 (en) * | 2004-09-04 | 2009-12-08 | Teva Pharmaceutical Industries Ltd | Isolated valacyclovir impurity, process for the preparation of valacyclovir impurity and use as a reference standard |
US20060081361A1 (en) * | 2004-09-13 | 2006-04-20 | Gabbey Lawrence W | Oil cooler with integral filter |
WO2006037125A1 (en) * | 2004-09-28 | 2006-04-06 | Teva Pharmaceutical Industries Ltd. | Process for preparing forms of atorvastatin calcium substantially free of impurities |
WO2006045120A2 (en) * | 2004-10-19 | 2006-04-27 | Teva Pharmaceutical Industries Ltd. | Purification of tegaserod maleate |
US7678551B2 (en) * | 2004-10-25 | 2010-03-16 | Seradyn, Inc. | Immunoassays for lamotrigine |
JP2007523213A (ja) * | 2004-12-23 | 2007-08-16 | テバ ファーマシューティカル インダストリーズ リミティド | 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法 |
CA2591666A1 (en) * | 2005-01-11 | 2006-07-20 | Teva Pharmaceutical Fine Chemicals S.R.L. | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride |
US20070037979A1 (en) * | 2005-02-22 | 2007-02-15 | Valerie Niddam-Hildesheim | Preparation of rosuvastatin |
KR100945763B1 (ko) | 2005-02-22 | 2010-03-08 | 테바 파마슈티컬 인더스트리즈 리미티드 | 로수바스타틴의 제조 방법 |
US20070167625A1 (en) * | 2005-02-22 | 2007-07-19 | Anna Balanov | Preparation of rosuvastatin |
CA2602073A1 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
EP1874754A1 (de) * | 2005-03-14 | 2008-01-09 | Teva Pharmaceutical Industries Ltd | Reines duloxetinhydrochlorid |
MX2007010268A (es) * | 2005-04-05 | 2008-02-19 | Teva Pharm Fine Chemicals Srl | Clorhidrato de atomoxetina estable, un proceso para la preparacion del mismo, y un control analitico de su estabilidad. |
WO2006108151A1 (en) * | 2005-04-06 | 2006-10-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of pregabalin |
US7488846B2 (en) * | 2005-04-11 | 2009-02-10 | Teva Pharmaceuical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
US20070066846A1 (en) * | 2005-04-11 | 2007-03-22 | Asher Maymon | Process for making (S)-Pregabalin |
EP1869007A1 (de) * | 2005-04-14 | 2007-12-26 | Teva Pharmaceutical Industries Ltd | Verfahren zur herstellung von quetiapinfumaraten |
US20080280977A1 (en) * | 2005-04-26 | 2008-11-13 | Sandor Molnar | Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid |
KR20090019016A (ko) * | 2005-05-10 | 2009-02-24 | 테바 파마슈티컬 인더스트리즈 리미티드 | 3-카르바모일메틸-5-메틸 헥산산의 광학 분할 |
MX2007000525A (es) * | 2005-05-10 | 2007-03-28 | Teva Pharma | Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella. |
WO2006122258A1 (en) * | 2005-05-10 | 2006-11-16 | Teva Pharmaceutical Industries Ltd. | Method for the preparation of pregabalin and salts thereof |
WO2006121557A1 (en) * | 2005-05-10 | 2006-11-16 | Teva Pharmaceutical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
WO2006127933A1 (en) | 2005-05-23 | 2006-11-30 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cinacalcet hydrochloride crystal form i |
WO2007002722A2 (en) * | 2005-06-27 | 2007-01-04 | Sicor, Inc. | Synthesis of anastrozole and purification of one of its intermediate |
EP1896398A2 (de) * | 2005-06-27 | 2008-03-12 | Sicor Inc. | Verunreinigung des anastrozol-zwischenprodukts und verwendungen dafür |
JP2008510840A (ja) * | 2005-07-05 | 2008-04-10 | テバ ファーマシューティカル インダストリーズ リミティド | モンテルカストの精製 |
CA2619576C (en) * | 2005-08-16 | 2011-12-06 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
US7446220B2 (en) * | 2005-09-19 | 2008-11-04 | Teva Pharmaceutical Industries Ltd. | Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid |
US20070197529A1 (en) * | 2005-12-01 | 2007-08-23 | Viviana Braude | Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
US7759500B2 (en) * | 2005-12-05 | 2010-07-20 | Teva Pharmaceutical Industries Ltd. | 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride |
WO2007069264A2 (en) * | 2005-12-15 | 2007-06-21 | Alembic Limited | Reference standards for determining the purity of telithromycin and processes therefor |
CA2626715A1 (en) * | 2005-12-27 | 2007-07-05 | Teva Pharmaceutical Industries Ltd. | Processes for preparing darifenacin hydrobromide |
WO2007126886A1 (en) * | 2006-03-27 | 2007-11-08 | Teva Pharmaceuticals Usa, Inc. | Process for preparing memantine hydrochloride substantially free of impurities |
US20080146675A1 (en) * | 2006-04-05 | 2008-06-19 | Eugenio Castelli | Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability |
GB0609835D0 (en) * | 2006-05-18 | 2006-06-28 | Pliva Istrazivanje I Razvoj D | Impurities of a pharmaceutical product |
WO2007139933A2 (en) * | 2006-05-24 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
EP2071032A3 (de) * | 2006-05-31 | 2009-07-08 | Teva Pharmaceutical Industries Ltd | Enzymatische Auflösung für die Herstellung von Pregablin-Zwischenprodukten |
EP1912931A2 (de) * | 2006-05-31 | 2008-04-23 | Teva Pharmaceutical Industries Ltd. | (s)-prägabalin-nitril-präparat |
SI2032712T1 (sl) * | 2006-06-29 | 2010-06-30 | Ivax Pharmaceuticals Sro | Regulacija proizvodnje kislinskega metabolita |
US20120142919A1 (en) * | 2006-08-02 | 2012-06-07 | Medichem, S.A. | Method for synthesizing lamotrigine |
EP2054396A1 (de) * | 2006-08-14 | 2009-05-06 | Lonza Ag | Verfahren zur herstellung von lamotrigin |
WO2008106179A1 (en) * | 2007-02-26 | 2008-09-04 | Teva Pharmaceutical Industries Ltd. | Intermediates and processes for the synthesis of ramelteon |
KR101036536B1 (ko) * | 2007-03-22 | 2011-05-24 | 테바 파마슈티컬 인더스트리즈 리미티드 | (s)-(+)-3-(아미노메틸)-5-메틸 헥산산의 합성 |
EP2024506A1 (de) * | 2007-04-11 | 2009-02-18 | Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság | Verfahren zur reduzierung des verunreinigungslevels bei der myophenolsäure-fermentierung |
EP2069320A2 (de) * | 2007-05-31 | 2009-06-17 | Teva Pharmaceutical Industries Ltd. | Verfahren zur synthese von ramelteon und seinen zwischenprodukten |
US20090137842A1 (en) * | 2007-10-03 | 2009-05-28 | Vollerner Yuri | Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof |
US8067423B2 (en) * | 2007-10-23 | 2011-11-29 | Teva Pharmaceutical Industries Ltd. | Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof |
WO2009056993A2 (en) * | 2007-11-01 | 2009-05-07 | Teva Pharmaceutical Industries Ltd. | A process for the synthesis of ramelteon and its intermediates |
US8486927B2 (en) * | 2007-11-09 | 2013-07-16 | Thar Pharmaceuticals | Crystalline forms of lamotrigine |
EP2252574A1 (de) * | 2008-03-06 | 2010-11-24 | Teva Pharmaceutical Industries Ltd. | Verfahren zur herstellung von dimer-unreinheitsfreiem o-desmethylvenlafaxin |
EP2297090A1 (de) * | 2008-06-23 | 2011-03-23 | Teva Pharmaceutical Industries Ltd. | Stereoselektive enzymatische synthese von (s)- bzw. (r)-iso-butyl-glutarsäure |
WO2010045565A1 (en) * | 2008-10-16 | 2010-04-22 | Teva Pharmaceutical Industries Ltd. | Process for the synthesis of ramelteon and its intermediates |
CA2795023A1 (en) * | 2010-03-29 | 2011-10-06 | Pliva Hrvatska D.O.O. | Crystal forms of o-desmethylvenlafaxine fumarate |
WO2012034065A1 (en) | 2010-09-09 | 2012-03-15 | Teva Pharmaceutical Industries Ltd. | Aliskiren intermediates and a process for analyzing the purity of aliskiren |
CN102766104A (zh) * | 2012-08-20 | 2012-11-07 | 三金集团湖南三金制药有限责任公司 | 一种治疗双向情感障碍及癫痫病药物拉莫三嗪的合成方法 |
WO2015092819A2 (en) | 2013-12-21 | 2015-06-25 | Nektar Therapeutics (India) Pvt. Ltd. | Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5- amine |
CN110467560A (zh) | 2018-05-09 | 2019-11-19 | 深圳微芯生物科技股份有限公司 | 一种苯基氨基丙酸钠衍生物、其制备方法和应用 |
KR102270026B1 (ko) * | 2020-01-31 | 2021-06-28 | 현대약품 주식회사 | (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법 |
CN113156009B (zh) * | 2021-04-20 | 2023-12-22 | 三金集团湖南三金制药有限责任公司 | 高效液相色谱分析拉莫三嗪的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5625169A (en) | 1979-06-01 | 1981-03-10 | Wellcome Found | Triazine derivative |
EP0021120B1 (de) | 1979-06-01 | 1983-04-06 | The Wellcome Foundation Limited | 3,5-Diamino-1,2,4-triazin-Derivate, Verfahren zur Herstellung dieser Verbindungen und pharmazeutische Zusammensetzungen sie enthaltend |
GB8613183D0 (en) | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
GB9426448D0 (en) * | 1994-12-30 | 1995-03-01 | Wellcome Found | Process |
RU2145602C1 (ru) * | 1994-12-30 | 2000-02-20 | Де Вэллкам Фаундейшн Лимитед | Способы получения ламотриджина, промежуточные соединения и способ получения фармацевтической композиции |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
-
1998
- 1998-06-10 GB GBGB9812413.4A patent/GB9812413D0/en not_active Ceased
-
1999
- 1999-02-24 EA EA199900159A patent/EA000666B1/ru not_active IP Right Cessation
- 1999-02-25 SG SG9901252A patent/SG85628A1/en unknown
- 1999-03-09 HR HR990074A patent/HRP990074A2/hr not_active Application Discontinuation
- 1999-03-09 KR KR1019990007632A patent/KR100322354B1/ko active IP Right Review Request
- 1999-03-10 ES ES99200695T patent/ES2178342T3/es not_active Expired - Lifetime
- 1999-03-10 PL PL99331870A patent/PL331870A1/xx not_active Application Discontinuation
- 1999-03-10 BR BR9900984-6A patent/BR9900984A/pt not_active IP Right Cessation
- 1999-03-10 DK DK99200695T patent/DK0963980T3/da active
- 1999-03-10 DE DE69901656T patent/DE69901656T2/de not_active Expired - Fee Related
- 1999-03-10 ZA ZA9901951A patent/ZA991951B/xx unknown
- 1999-03-10 EP EP01203376A patent/EP1170588A1/de not_active Withdrawn
- 1999-03-10 EP EP99200695A patent/EP0963980B1/de not_active Expired - Lifetime
- 1999-03-10 PT PT99200695T patent/PT963980E/pt unknown
- 1999-03-10 TR TR1999/00520A patent/TR199900520A2/xx unknown
- 1999-03-10 JP JP11063792A patent/JP2989189B1/ja not_active Expired - Fee Related
- 1999-03-10 AR ARP990101018A patent/AR014074A1/es not_active Application Discontinuation
- 1999-03-10 HU HU9900592A patent/HUP9900592A3/hu unknown
- 1999-03-10 CA CA002265194A patent/CA2265194C/en not_active Expired - Fee Related
- 1999-03-10 NO NO991151A patent/NO991151L/no unknown
- 1999-03-10 ID IDP990201D patent/ID22957A/id unknown
- 1999-03-10 SI SI9930088T patent/SI0963980T1/xx unknown
- 1999-03-10 MA MA25489A patent/MA24777A1/fr unknown
- 1999-03-10 US US09/265,670 patent/US6333198B1/en not_active Expired - Fee Related
- 1999-03-10 AP APAP/P/1999/001481A patent/AP9901481A0/en unknown
- 1999-03-10 NZ NZ334590A patent/NZ334590A/xx unknown
- 1999-03-10 AT AT99200695T patent/ATE218552T1/de not_active IP Right Cessation
- 1999-03-10 CN CN99103445A patent/CN1238454A/zh active Pending
- 1999-03-10 PE PE1999000190A patent/PE20000332A1/es not_active Application Discontinuation
- 1999-03-10 AP APAP/P/2001/002286A patent/AP0102286A0/en unknown
- 1999-03-10 AU AU20319/99A patent/AU2031999A/en not_active Abandoned
- 1999-03-10 YU YU12399A patent/YU12399A/sh unknown
-
2000
- 2000-01-17 UY UY25946A patent/UY25946A1/es unknown
- 2000-07-25 CN CN00122208A patent/CN1306210A/zh active Pending
-
2001
- 2001-09-06 AP AP2001002286A patent/AP2001002286A0/xx unknown
-
2003
- 2003-06-17 NO NO20032753A patent/NO20032753D0/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22957A (id) | Senyawa dan penggunaannya | |
ID29591A (id) | Senyawa-senyawa kuinolina dan kuinoksalina | |
ID22889A (id) | Komposisi kopolimer etilena dan penggunaannya | |
ID23575A (id) | Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina | |
ID24839A (id) | Senyawa-senyawa triazol dan penggunaannya | |
ID28787A (id) | 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya | |
ID24196A (id) | Komposisi dan penggunaan | |
ID28990A (id) | Herbisida-herbisida dengan urea aminofenilsulfonil asilasi | |
ID19422A (id) | Piridina dan bifenil tersubstitusi | |
ID24148A (id) | Turunan-turunan fitostfrol dan/atau fitostanol | |
ID25977A (id) | Popok sekali pakai | |
ID24555A (id) | Popok sekali pakai | |
ID26848A (id) | Koupling untuk gigi-gigi eksapator dan sejenisnya | |
ID23076A (id) | Popok sekali pakai | |
ID19824A (id) | Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya | |
NO20001830D0 (no) | Ny kombinasjon | |
NO20005503D0 (no) | Ny anvendelse | |
ID28846A (id) | 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya | |
ID29943A (id) | Senyawa dds dan metode pengukurannya | |
ID26599A (id) | Turunan triazola dan imidazola | |
ID22956A (id) | Sintesa disulfida dan polisulfida organik | |
ID27480A (id) | Pembungkusan berstruktur dan elemennya | |
ID23083A (id) | Popok sekali pakai | |
ID28852A (id) | Bahan-bahan elektroluminesensi | |
ID16889A (id) | Senyawa turunan alkilaminobenzotiazol dan benzoksazol |